brofaromine has been researched along with Depressive Disorder in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.00) | 18.7374 |
| 1990's | 27 (90.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Möller, HJ; Müller, H; Volz, HP | 2 |
| Bakish, D; Bradwejn, J; Chouinard, G; Kennedy, SH; Kukha-Mohamad, SA; Kutcher, SP; Nair, NP; Remick, RA; Saxena, BM; Sharma, V | 3 |
| Boulton, AA; D'Souza, J; Davis, BA; Durden, DA; Goldbloom, DS; Kennedy, SH | 1 |
| Bellaire, J; Heimann, H; Laux, G; Möller, HJ; Volz, HP | 1 |
| Dijken, WA; Duivenvoorden, H; Haffmans, PM; Hoencamp, E; Knegtering, H | 1 |
| Faltus, F; Magyar, I; Möller, HJ; Volz, HP | 1 |
| Dijken, WA; Haffmans, PM; Hoencamp, E; Hoogduin, CA; Nolen, WA; van Dyck, R | 1 |
| Katz, RJ; Rosenthal, M | 1 |
| Möller, HJ; Volz, HP | 2 |
| Verhoeven, WM | 1 |
| Bouvy, PF; Haffmans, PM; Hoencamp, E; Nolen, WA | 1 |
| Hoffmans, J; Knegtering, R | 1 |
| Bouvy, PF; Duivenvoorden, HJ; Haffmans, PM; Nolen, WA | 1 |
| Möller, HJ; Müller, H; Preussler, B; Sturm, Y; Volz, HP | 1 |
| Gleiter, CH; Möller, HJ; Struck, M; Volz, HP; Waldmeier, PC | 1 |
| Gleiter, CH; Möller, HJ; Volz, HP | 1 |
| Alvarez, E; Artigas, F; Celada, P; Pérez, J | 1 |
| Antonin, KH; Bieck, PR; Schmidt, E | 1 |
| Delcker, A; Gaertner, HJ | 1 |
| Haffmans, PM; Hoencamp, E | 1 |
| Becker, T; Beckmann, H; Classen, W; Laux, G; Lesch, KP; Riederer, P; Sofic, E; Struck, M | 1 |
| Becker, T; Bieck, P; Fritze, J; Laux, G; Riederer, P; Sofic, E; Ziegler, V | 1 |
| Becker, T; Fritze, J; Laux, G; Riederer, P; Ziegler, V | 1 |
| Delini-Stula, A; Heath, WR; Schiwy, W | 1 |
| Möller, HJ; Wendt, G | 1 |
| Benkert, O; Demisch, L; Gerken, A; Holsboer, F; Steiger, A | 1 |
4 review(s) available for brofaromine and Depressive Disorder
| Article | Year |
|---|---|
Brofaromine in endogenous depression.
Topics: Antidepressive Agents; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Piperidines | 1994 |
Reversible monoamine oxidase-A inhibitors in resistant major depression.
Topics: Antidepressive Agents; Depressive Disorder; Drug Resistance; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines | 1993 |
Brofaromine--a review of its pharmacological properties and therapeutic use.
Topics: Animals; Brain Chemistry; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Piperidines | 1996 |
[Brofaromine--a selective, reversible and short-acting MAO-A inhibitor].
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Piperidines | 1989 |
18 trial(s) available for brofaromine and Depressive Disorder
| Article | Year |
|---|---|
Are there any differences in the safety and efficacy of brofaromine and imipramine between non-elderly and elderly patients with major depression?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Piperidines; Psychiatric Status Rating Scales | 1995 |
A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression.
Topics: Adolescent; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Personality Inventory; Piperidines | 1994 |
Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Piperidines; Psychiatric Status Rating Scales; Tranylcypromine | 1994 |
Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy.
Topics: Adult; Antidepressive Agents; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium; Male; Maprotiline; Middle Aged; Monoamine Oxidase Inhibitors; Personality Assessment; Personality Inventory; Piperidines; Treatment Outcome | 1994 |
Brofaromine in treatment-resistant depressed patients--a comparative trial versus tranylcypromine.
Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Personality Inventory; Piperidines; Tranylcypromine | 1994 |
Brofaromine versus lithium addition to maprotiline. A double-blind study in maprotiline refractory depressed outpatients.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium; Male; Maprotiline; Middle Aged; Monoamine Oxidase Inhibitors; Personality Inventory; Piperidines; Prospective Studies; Recurrence | 1994 |
Brofaromine in elderly major depressed patients--a comparative trial versus imipramine.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Piperidines; Psychiatric Status Rating Scales | 1993 |
Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Canada; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenelzine; Piperidines; Psychiatric Status Rating Scales; Tranylcypromine | 1993 |
The selective reversible monoamine oxidase-A inhibitor brofaromine and sleep.
Topics: Adult; Aged; Depressive Disorder; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Piperidines; Regression Analysis; Sleep Wake Disorders | 1993 |
Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Monoamine Oxidase Inhibitors; Piperidines; Psychiatric Status Rating Scales; Sleep, REM; Tranylcypromine | 1993 |
Effect of initial treatment with antidepressants as a predictor of outcome after 8 weeks.
Topics: Adult; Affect; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Geriatric Assessment; Humans; Imipramine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Personality Inventory; Piperidines; Prognosis; Treatment Outcome | 1995 |
How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Piperidines; Psychiatric Status Rating Scales | 1996 |
Brofaromine versus imipramine in in-patients with major depression--a controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospitalization; Humans; Imipramine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Piperidines; Sleep Wake Disorders | 1997 |
Brofaromine in major depressed patients: a controlled clinical trial versus imipramine and open follow-up of up to one year.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Monoamine Oxidase Inhibitors; Personality Inventory; Piperidines | 1992 |
Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studies.
Topics: Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Piperidines; Psychiatric Status Rating Scales; Single-Blind Method | 1992 |
Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder.
Topics: Benzamides; Catecholamines; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines; Psychiatric Status Rating Scales | 1990 |
Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nomifensine; Piperidines; Psychiatric Status Rating Scales; Random Allocation; Tranylcypromine | 1989 |
[Brofaromine--a selective, reversible and short-acting MAO-A inhibitor].
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Humans; Piperidines | 1989 |
9 other study(ies) available for brofaromine and Depressive Disorder
| Article | Year |
|---|---|
Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa.
Topics: Adult; Bulimia; Depressive Disorder; Female; Humans; Monoamine Oxidase Inhibitors; Phenylacetates; Piperidines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Single-Blind Method | 1994 |
Adverse interaction of cyproheptadine with serotonergic antidepressants.
Topics: Acute Disease; Cyproheptadine; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Paranoid Disorders; Piperidines; Recurrence | 1994 |
Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
Topics: Adult; Ambulatory Care; Depressive Disorder; Female; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenelzine; Piperidines; Serotonin; Treatment Outcome | 1992 |
Clinical pharmacology of reversible MAO-A inhibitors.
Topics: Benzamides; Depressive Disorder; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Piperidines | 1992 |
Tolerability and antidepressive effect of brofaromine, a short-acting reversible MAO inhibitor--an open study.
Topics: Adult; Aged; Blood Pressure; Depressive Disorder; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Piperidines; Psychiatric Status Rating Scales; Pulse | 1991 |
Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients.
Topics: Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Maprotiline; Monoamine Oxidase Inhibitors; Pilot Projects; Piperidines; Psychiatric Status Rating Scales | 1991 |
Brofaromine (CGP 11 305 A): estimation of plasma concentrations by a biologic technique as compared to liquid chromatography.
Topics: Adult; Aged; Chromatography, Liquid; Depressive Disorder; Female; Humans; In Vitro Techniques; Male; Middle Aged; Mitochondria; Monoamine Oxidase Inhibitors; Piperidines; Placenta; Pregnancy | 1990 |
Brofaromine (CGP 11 305 A) in treatment of depression: biological estimation of plasma concentrations.
Topics: Adult; Aged; Depressive Disorder; Female; Humans; Male; Middle Aged; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines; Placenta; Psychiatric Status Rating Scales | 1990 |
Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depression.
Topics: Adult; Aged; Blood Platelets; Depressive Disorder; Dexamethasone; Electroencephalography; Female; Humans; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Personality Assessment; Piperidines; Serotonin; Sleep, REM; Tyramine | 1987 |